Objective:To explore the effect of Shenmai Injection(SMI)on the long-term prognosis of patients with chronic heart failure(CHF).Methods:The Hospital Information System was used to extract data of CHF patients,and the retrospective cohort study was conducted for analysis.In non-exposed group,standardized Western medicine treatment and Chinese patent medicine or decoction were applied without combination of SMI while in the exposed group,SMI were applied for more than 7 days.Evaluation indicators are followed with New York Heart Association functional classification(NYHA classification),left ventricular ejection fraction(LVEF),N-terminal brain natriuretic peptide precursor(NT-ProBNP),cardiogenic death and heart failure(HF)readmission.Statistical analysis includes Kaplan-Meier analysis and Cox regression which are used to explore the relationship between SMI and outcome events.Results:A total of 1,211 eligible CHF patients were involved and finally 1,047 patients were followed up successfully.After treatment,the cases of NYHA classification decline in the exposed and non-exposed groups accounted for 64.30％and 43.45％,respectively;the improvement values of LVEF were 8.89％and 7.91％,respectively;the improvement values of NT-ProBNP were 909 pg/mL and 735 pg/mL,respectively.After exposure on SMI,the rates of cardiogenic death and HF readmission reduced from 15.43％to 10.18％and 38.93％to 32.37％.According to Kaplan-Meier analysis,the log-rank P value of SMI and cardiogenic death was 0.014,while the counterpart of SMI and HF readmission was 0.025.Cox regression analysis indicated that for cardiogenic death,age,cardiomyopathy,diabetes,and NYHA classification were risk factors while β-blockers,aldosterone receptor antagonists,Chinese patent medicine/decoction and SMI were protective factors.Likewise,for HF readmission,age,cardiomyopathy,and NYHA classification were risk factors while SMI was a protective factor.Conclusion:Combination with SMI on the standardized Western medicine treatment can effectively reduce cardiogenic mortality and readmission rate in CHF patients,and thereby improve the long-term prognosis.

GUAN Hui;DAI Guo-hua;GAO Wu-lin;ZHANG Tong;SUN Cong;REN Li-li;HOU Xiao-ming;LIU Zhang

The First Clinical Medical College,Shandong University of Traditional Chinese Medicine,Jinan(250014),China;Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan(250011),China

中国结合医学杂志（英文版）

[1]GUAN Hui;DAI Guo-hua;GAO Wu-lin;ZHANG Tong;SUN Cong;REN Li-li;HOU Xiao-ming;LIU Zhang-.Effect of Shenmai Injection on Long-Term Prognosis of Patients with Chronic Heart Failure:A Multicenter,Large Sample Capacity,Long-Term Follow-Up Retrospective Cohort Study)[J].中国结合医学杂志（英文版）,2022(04):312-318

Shenmai

Effect,Injection,Long,Term,Prognosis,Patients,Chronic,Heart,Failure,Multicenter,Large,Sample,Capacity,Follow,Up,Retrospective,Cohort,Study,Objective,To,explore,SMI,long,prognosis,patients,chronic,heart,failure,CHF,Methods,Hospital,Information,System,was,used,extract,data,retrospective,cohort,study,conducted,analysis,exposed,standardized,medicine,treatment,Chinese,patent,decoction,were,applied,without,combination,while,more,than,days,Evaluation,indicators,are,followed,New,York,Association,functional,classification,NYHA,left,ventricular,ejection,fraction,LVEF,terminal,brain,natriuretic,peptide,precursor,NT,ProBNP,cardiogenic,death,readmission,Statistical,includes,Kaplan,Meier,Cox,regression,which,relationship,between,outcome,events,Results,total,eligible,involved,finally,successfully,After,cases,decline,groups,accounted,respectively,improvement,values,pg,exposure,rates,reduced,from,According,log,rank,counterpart,indicated,that,age,cardiomyopathy,diabetes,risk,factors,blockers,aldosterone,receptor,antagonists,protective,Likewise,Conclusion,Combination,can,effectively,mortality,thereby

0.483632